Equities
Health CareHealth Care Providers
  • Price (USD)197.60
  • Today's Change3.22 / 1.66%
  • Shares traded1.86m
  • 1 Year change-4.75%
  • Beta1.5002
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year IQVIA Holdings Inc grew revenues 3.98% from 14.41bn to 14.98bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 24.47% net income growth from 1.09bn to 1.36bn.
Gross margin35.17%
Net profit margin9.21%
Operating margin13.52%
Return on assets5.31%
Return on equity22.00%
Return on investment7.13%
More ▼

Cash flow in USDView more

In 2023, IQVIA Holdings Inc increased its cash reserves by 13.16%, or 160.00m. The company earned 2.15bn from its operations for a Cash Flow Margin of 14.34%. In addition the company used 1.60bn on investing activities and also paid 382.00m in financing cash flows.
Cash flow per share13.77
Price/Cash flow per share13.91
Book value per share38.36
Tangible book value per share-70.80
More ▼

Balance sheet in USDView more

IQVIA Holdings Inc has a Debt to Total Capital ratio of 65.98%, a lower figure than the previous year's 212.26%.
Current ratio0.8055
Quick ratio--
Total debt/total equity1.94
Total debt/total capital0.6598
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 27.35%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)46.62
EPS (TTM) vs
TTM 1 year ago
27.86
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.